An environmental risk assessment (ERA) is now required for all new pharmaceutical product marketing authorisation applications. The author outlines the steps to this procedure.
D.F. de Roode
Advertisement
D.F. de Roode is Regulatory Affairs Manager at NOTOX B.V. Tel. +31(0)73 640 67 00 Fax: +31(0)73 640 67 99 Email: daphne.de.roode@notox.nl
Articles by D.F. de Roode
Advertisement
Latest Updated Articles
- Assessing environmental risk of pharmaceuticals
Published: June 1st 2010 | Updated:
Advertisement
Advertisement
